Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmex Group is a leading Ukrainian pharmaceutical company and a sophisticated research and production complex located in Boryspil, near Kyiv. The company specializes in the development and manufacture of high-tech generic drugs and biotechnological products, operating within a state-of-the-art facility that meets international GMP standards. Pharmex Group offers comprehensive contract manufacturing (CMO) and development (CDMO) services, supporting partners with formulation, analytical testing, and full-scale production. Their diverse product portfolio focuses on critical therapeutic areas such as oncology, cardiology, and neurology. As one of the most modern pharmaceutical sites in Eastern Europe, the company plays a vital role in providing affordable, high-quality medicines to the Ukrainian market and international export regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmex Group Omnifarm Kyiv.